Mayne Pharma | MYX - 贷款资金

股票价格
2.20
每天变化
0.07 3.29%
每月一次
-15.71%
每年
-69.57%
Q1 预测
2.15


金融业
股票价格
AUD
资产
AUD 1.14B
现金及等价物
AUD 110.07M
销售成本
AUD 43.74M
流动资产
AUD 460.59M
流动负债
AUD 313.94M
债务
AUD 38.82M
EBIT
AUD -16.2M
EBITDA
AUD 20.9M
员工
450
EPS每股收益
AUD -0.15
股本和储备
AUD 454.19M
销售毛利
AUD 86.13M
债务利息支出
AUD 1.2M
贷款资金
AUD 2.66M
市值
AUD 187.16M
净收入
AUD -103.68M
营业费用
AUD 103.54M
营业利润
AUD -3.3M
普通股股本
AUD 81.25M
税前利润
AUD -14.7M
销售收入
AUD 212.07M
销售和管理费用
AUD 54.8M
股票
AUD 74.63M
贸易债权人
AUD 30.25M
应收帐款人
AUD 193.22M


贷款资金 更改 日
Ansell USD 751.6M 113.1M 2025-12
Avita Medical AUD 42.24M 1.25M 2024-12
Cochlear AUD 200M 6.5M 2025-12
CSL USD 10.42B 273M 2025-12
Healius AUD 1.22B 103M 2024-12
Integral Diagnostics AUD 341.63M 1.98M 2024-06
Medical Developments International AUD 1.5M 167K 2025-12
Nanosonics AUD 3.21M 1.06M 2025-12
Polynovo AUD 15.39M 663K 2025-12
Ramsay Health Care AUD 11.2B 5.74B 2025-12
ResMed USD 403.92M 4.74M 2025-12
Sigma Healthcare AUD 1.88B 1.75B 2025-12
Sonic Healthcare AUD 4.19B 333.39M 2024-12
Telix Pharmaceuticals AUD 448.45M 76.97M 2025-12